Treating Hepatitis C
نویسندگان
چکیده
منابع مشابه
Sofosbuvir-velpatasvir for treating chronic hepatitis C.
On Jan 25, 2017, the UK National Institute for Health and Care Excellence (NICE) published guidance recommending sofosbuvirvelpatasvir (Gilead Sciences Ltd, Uxbridge, UK) as an option for treating chronic hepatitis C in adults (table), only if the manufacturing company provides the drug with the price reduction in the simple discount agreement. NICE appraised sofosbuvirvelpatasvir as a single t...
متن کاملNatural Interventions for Treating Hepatitis C
Chronic hepatitis C, caused by the hepatitis C virus (HCV), is occurring at epidemic proportions. It is estimated that 3.9 million individuals are infected in the United States. There are four times more people infected with HCV than with human immunodeficiency virus (HIV), with more than 170 million people infected with HCV worldwide.' HCV is the most common cause of chronic liver disease, cir...
متن کاملTreating hepatitis C: are children the same as adults?
See " The combination of ribavirin and pegin-terferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C, " by Schwarz KB, Gonza-lez–Peralta RP, Murray KF, et al, on page 450. S ignificant progress has been made in the management of hepatitis C virus (HCV) infection over the last decade. Combination treatment with pegylated inter-feron (PEG-IFN) plus ...
متن کاملFeasibility of Treating Hepatitis C in a Transient Jail Population
Jails represent a critical component of the public health response to HCV elimination. We report on outcomes of 104 patients receiving HCV treatment from January 1, 2014 to June 30, 2016 in a large urban jail setting. Our data demonstrate that treatment in jails is feasible, but many barriers remain.
متن کاملTreating viral hepatitis C: efficacy, side effects, and complications.
The treatment of hepatitis C has dramatically improved over the past decade. Unlike any other chronic viral infection, a significant proportion of patients with chronic hepatitis C can be cured. However, the current standard therapy--pegylated interferon alpha and ribavirin--has its limitations. Limited efficacy in patients with hepatitis C virus (HCV) genotype 1 and the side effect profile wil...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA
سال: 2018
ISSN: 0098-7484
DOI: 10.1001/jama.2018.15997